Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.
| Website | https://www.imubiosciences.com/ |
| Employees | 84 (37 on RocketReach) |
| Founded | 2019 |
| Phone | +1 978-425-3100 |
| Industry | Biotechnology Research |
| Keywords | Immunomodulation, Systems Biology, Immuno-Oncology |
| Competitors | Amgen, Regeneron, Gilead Sciences, Biogen, Roche, Johnson & Johnson, Novartis, Pfizer, Merck & Co., Inc., AstraZeneca +39 more (view full list) |
Looking for a particular IMU Biosciences employee's phone or email?
IMU Biosciences Questions
Tom Hayday is the Co-founder and Chief Research Officer (CRO) of IMU Biosciences.
37 people are employed at IMU Biosciences.
IMU Biosciences is based in London, England.
Top IMU Biosciences Employees
-
12
-
John Baker
Chief Executive Officer at IMU Biosciences
Cambridge, MA, US12 -
23
-
Denise Emsden
Vice President, People at IMU Biosciences
Cambridge, GB3 -
21
-
21
G2Crowd Trusted
300K+
Plugin Users
